Ingevity Corporation (NGVT)
NYSE: NGVT · Real-Time Price · USD
73.11
+2.92 (4.16%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Ingevity Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 97.4 | 78.1 | 68 | 95.9 | 76.7 | 275.4 |
Cash & Short-Term Investments | 97.4 | 78.1 | 68 | 95.9 | 76.7 | 275.4 |
Cash Growth | 26.66% | 14.85% | -29.09% | 25.03% | -72.15% | 6.87% |
Accounts Receivable | 155.8 | 127.2 | 131.7 | 182 | 224.8 | 161.7 |
Inventory | 154 | 186 | 195.9 | 308.8 | 335 | 241.2 |
Other Current Assets | 50.8 | 62.9 | 97.6 | 71.9 | 46.8 | 46.6 |
Total Current Assets | 543.8 | 454.2 | 493.2 | 658.6 | 683.3 | 724.9 |
Net Property, Plant & Equipment | 608 | 637.6 | 687.6 | 829.3 | 855.2 | 772.1 |
Other Intangible Assets | 137.3 | 176.1 | 278.8 | 336.1 | 404.8 | 337.6 |
Goodwill | 4.3 | 4.3 | 175.2 | 527.5 | 518.5 | 442 |
Long-Term Investments | 169.2 | 167.5 | 168.9 | 178.3 | 187.8 | 111.4 |
Other Long-Term Assets | 160.7 | 211.4 | 218.9 | 93.5 | 86.9 | 81 |
Total Assets | 1,538 | 1,651 | 2,023 | 2,623 | 2,737 | 2,469 |
Accounts Payable | 88 | 92 | 94.5 | 158.4 | 174.8 | 125.8 |
Accrued Expenses | 85.2 | 182.6 | 85.4 | 92.2 | 107.7 | 99.9 |
Current Portion of Long-Term Debt | 144 | 47.1 | 61.3 | 84.4 | 0.9 | 19.6 |
Current Portion of Leases | 12.2 | 11.8 | 14.4 | 18.7 | 16.5 | 17.4 |
Other Current Liabilities | 8.2 | 7.8 | 8.5 | 9.2 | 3.6 | 6.2 |
Total Current Liabilities | 337.6 | 341.3 | 264.1 | 362.9 | 303.5 | 268.9 |
Long-Term Debt | 1,056 | 1,161 | 1,340 | 1,383 | 1,473 | 1,250 |
Long-Term Leases | 23.9 | 22.4 | 33.6 | 48.6 | 40.8 | 36.2 |
Other Long-Term Liabilities | 72.9 | 96.3 | 190 | 197.6 | 221.4 | 240.1 |
Total Long-Term Liabilities | 1,153 | 1,280 | 1,563 | 1,629 | 1,735 | 1,526 |
Total Liabilities | 1,491 | 1,621 | 1,827 | 1,992 | 2,038 | 1,795 |
Common Stock | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 |
Treasury Stock | -663.6 | -571.8 | -512.6 | -509.5 | -416 | -272.1 |
Additional Paid-in Capital | 209.1 | 195.7 | 176.8 | 164.9 | 153 | 136.3 |
Accumulated Other Comprehensive Income | 1 | 0.5 | -41.4 | -26.7 | -46.8 | 13.1 |
Retained Earnings | 500 | 404.9 | 572 | 1,002 | 1,008 | 796.1 |
Shareholders' Equity | 46.9 | 29.7 | 195.2 | 631.4 | 698.3 | 673.8 |
Total Liabilities & Equity | 1,538 | 1,651 | 2,023 | 2,623 | 2,737 | 2,469 |
Total Debt | 1,236 | 1,243 | 1,449 | 1,535 | 1,531 | 1,323 |
Net Cash (Debt) | -1,139 | -1,165 | -1,381 | -1,439 | -1,454 | -1,048 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -31.64 | -32.15 | -38.02 | -39.19 | -37.80 | -26.16 |
Book Value | 46.9 | 29.7 | 195.2 | 631.4 | 698.3 | 673.8 |
Book Value Per Share | 1.30 | 0.82 | 5.37 | 17.20 | 18.15 | 16.82 |
Tangible Book Value | -94.7 | -150.7 | -258.8 | -232.2 | -225 | -105.8 |
Tangible Book Value Per Share | -2.63 | -4.16 | -7.12 | -6.33 | -5.85 | -2.64 |